Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.38737 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.43192 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.43713 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.4843 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.46814 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.49801 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.47739 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.30585 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.47554 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.48227 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.61206 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.42226 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.48353 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.49276 | 71 |